Skip to main content

Table 4 Demographic features of subjects evaluated in this study

From: Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA

Demographic

 

Clinical diagnosis of prospectively enrolled patients

CRCb

Gastric cancer

Liver cancer

AAa

NAa

Hyperplastic/other polyp

NEDb

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

Sex

Male

133 (54.3)

9 (39.1)

8 (80.0)

2 (66.7)

22 (53.7)

12 (66.7)

114 (46.5)

Female

112 (45.7)

14 (60.9)

2 (20.0)

1 (33.3)

19 (46.3)

6 (33.3)

131 (53.5)

Age

≤ 49

36 (14.7)

9 (39.1)

1 (10.0)

–

11 (26.8)

4 (22.2)

87 (35.5)

50–59

62 (25.3)

7 (30.4)

5 (50.0)

1 (33.3)

17 (41.5)

9 (50.0)

105 (42.9)

60–69

79 (32.2)

5 (21.7)

3 (30.0)

2 (66.7)

12 (29.3)

5 (27.8)

47 (19.2)

≥ 70

68 (27.8)

2 (8.7)

1 (10.0)

–

1 (2.4)

–

6 (2.4)

Total

 

245

23

10

3

41

18

245

  1. aAA advanced adenomas (≥ 1.0 cm), NA non-advanced adenomas (< 1.0 cm)
  2. bCRC colorectal cancer, NED no evidence of disease